James C Stanley

Title: Innovations by James C. Stanley in Anticoagulation Research

Introduction

James C. Stanley is an accomplished inventor based in Ann Arbor, MI. He has made significant contributions to the field of anticoagulation through his innovative research and development of synthetic peptides. With a total of 4 patents, Stanley's work focuses on creating less toxic agents for the reversal of heparin and low molecular weight heparin anticoagulation.

Latest Patents

Stanley's latest patents include the development of synthetic protamine-like polycationic peptides. These peptides are designed to have a total cationic charge that is less than that of n-protamine. In preferred embodiments, arginine residues of n-protamine are replaced with lysine residues to facilitate easier manufacturing. Additionally, selective positively charged arginine residues are substituted with uncharged amino acid residues or their analogs, such as glycine or glutamine, to reduce the total cationic charge on the polycationic peptide to a range of about +14 to +18, preferably +16 to +18. Specific embodiments include sequences of 29 and 32 amino acid residues, where clusters of positively charged amino acids are separated by neutral amino acids. Modifications at the C-terminus and N-terminus help mitigate in vivo degradation by carboxypeptidases and aminopeptidases. Furthermore, the incorporation of α-helix forming amino acids, such as glutamic acid, promotes anticoagulation reversal.

Career Highlights

James C. Stanley is affiliated with the University of Michigan, where he continues to advance his research in the field of anticoagulation. His innovative work has garnered attention and respect within the scientific community.

Collaborations

Stanley has collaborated with notable colleagues, including Thomas W. Wakefield and Philip C. Andrews, to further enhance the impact of his research.

Conclusion

James C. Stanley's contributions to the field of anticoagulation through his innovative peptides represent a significant advancement in medical science. His work not only highlights the importance of research in this area but also showcases the potential for future developments in safer anticoagulation therapies.